IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Aug 1, 2025, 4:00 PM
1.280
-0.030 (-2.29%)
After-hours: Aug 1, 2025, 4:40 PM EDT
Model N Employees
IGM Biosciences had 149 employees as of December 31, 2024. The number of employees decreased by 75 or -33.48% compared to the previous year.
Employees
149
Change (1Y)
-75
Growth (1Y)
-33.48%
Revenue / Employee
$973,490
Profits / Employee
-$358,289
Market Cap
78.85M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 149 | -75 | -33.48% |
Dec 31, 2023 | 224 | -34 | -13.18% |
Dec 31, 2022 | 258 | 66 | 34.38% |
Dec 31, 2021 | 192 | 85 | 79.44% |
Dec 31, 2020 | 107 | 43 | 67.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IGMS News
- 4 weeks ago - IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right - GlobeNewsWire
- 7 months ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 7 months ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 9 months ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 10 months ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 10 months ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 10 months ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons